Kezar Life Sciences
Presence
Kezar Life Sciences is one of the...
Kezar Life Sciences is a company listed under the stock ticker KZR (US).
Executives
View the org chart displaying its 24 main executives
Most searched biographies at Kezar Life Sciences
- Christopher Kirk, Director and Chief Executive Officer
- Elizabeth Garner, Director
- Micki Klearman, Director
Popular executive movements at Kezar Life Sciences
- Christopher Kirk who is Director, President and Chief Scientific Officer, will be promoted to Director and Chief Executive Officer on Nov. 3, 2023 (posted on October 4 2023).
Create your alert
to follow the executive moves at Kezar Life Sciences.
Biotechnology
Kezar Life Sciences has 2,276 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Kezar Life Sciences
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
- Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Announces Topline Results from PRESIDIO Trial of Zetomipzomib for the Treatment of Dermatomyositis and Polymyositis
- Kezar Life Sciences to Participate in Two Upcoming Investor Conferences :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Announces Completion of Enrollment of Its Phase 2 PRESIDIO Clinical Trial of KZR-616 in Polymyositis and Dermatomyositis :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Reports Second Quarter Financial Results and Provides Business Updates :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021 :: Kezar Life Sciences, Inc. (KZR)
- Kezar Life Sciences Announces Formation of Clinical Advisory Committee :: Kezar Life Sciences, Inc. (KZR)
- Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021 :: Kezar Life Sciences, Inc. (KZR)
- View more press releases Close
Social media about Kezar Life Sciences
- Kezar Life Sciences on Wikipedia, Google News & Yahoo Finance
- Kezar Life Sciences on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Christopher Kirk 
Call Kezar Life Sciences at +1 650...
